🆚 FlipBuilder vs. Issuu
FlipBuilder
IssuuType
About
FlipBuilder Flip PDF is a flipbook creation application for 
Windows and macOS that converts PDFs and images into interactive HTML5 publications and is offered with a lifetime license.
It provides a multimedia editor offering timeline controls, publishing to 
HTML, EXE, ZIP, and APK formats, batch conversions, right-to-left language support, and plugins for banners, news tickers, and photo sliders.
Issuu is a digital publishing platform that converts static PDFs into interactive online flipbooks.
It provides multi-format content creation from a single upload, website embedding and social sharing, analytics on read time, impressions, and clicks, digital sales of subscriptions and single issues, and lead generation forms that collect reader emails.
Headquarters
Pricing
(17 templates) $149
(23 templates) $399
(4 computers) $699
(unlimited documents x 500 pages) $300/year
(all features) $2,712/year
(2 members, 2 workspaces) $6,000/year
Categories
Popularity
Determined by the number of sites using each technology.
Market share
Popularity by country
Determined by the number of sites detected from each country.
Awards
- 🥇 Most popular in the United States in the Flipbook Software category.
- 🥇 Most popular in the United Kingdom in the Flipbook Software category.
- 🥇 Most popular in Vietnam in the Flipbook Software category.
- 🥇 Most popular in Spain in the Flipbook Software category.
- 🥇 Most popular in Italy in the Flipbook Software category.
Popularity by domain category
Determined by the number of sites in each category.
Top sites
Top-ranked sites that use these technologies.
Compare alternatives
Technologies with similar characteristics.
Wonder Idea company profile🗃️ About This Data
- We evaluate the popularity of technologies based on the number of websites where we detect their usage.
- Technologies without a detectable web footprint, and those we do not track, are not reflected in the calculated market share.
- Statistics were last calculated on .
- For more details, see our methodology and disclaimer.